top of page
​Professor Charles Swainson, Dunedin Solutions

Professor Charles P. Swainson

Chief Medical Officer

Biotech and Lifesciences 

Board member of start-up companies, Medical adviser to entrepreneurs:

  • Over 40 years’ experience in health care​

  • Board level responsibility for digital transformation​

  • Board responsibility for R&D and University liaison

Serial Investor

Angel investor, Board member and advisor. Investor in 14 start-up companies over 9 year:

  • Angel investor in 14 companies​

  • Board member and advisory roles​

  • Executive coaching

Government and Health Policies

Strategic advisor, digital, health policy. Serve as Chair across influential government bodies Government adviser on digital policy:

  • Chair and member of influential groups and committees​

  • Adviser on clinical digital transformation​​

  • Advice to Ministers on funding Orphan Drugs

Executive Leader (UK & China)

Public sector Board member and medical executive (UK), Private sector Board member and executive (China):

  • Over 30 years’ experience in clinical and academic leadership​

  • 4 years as Board medical director​

  • Board chair and member of charities and start ups

Charles joined Dunedin solutions in 2017. His core expertise is strategic planning and execution as applied to new ideas in medical and biotech innovations. New ideas and solutions need careful testing against real world problems, the developing science and new trends in medicine.

Charles trained as a kidney specialist in the UK and worked in New Zealand for a while. He was a consultant renal specialist in Edinburgh for over 30 years. Charles moved into clinical leadership and management in 1992 and was the project doctor for the design and building of the new Royal Infirmary in Edinburgh. He was the medical director and Board member of the Royal Infirmary and Lothian Health Board for 12 years. He had responsibility for medical service planning, patient safety, R & D, University liaison and digital services as well as the medical, dental and allied health professionals. He was appointed to an honorary Chair in the University of Edinburgh in 2007.

Charles is a serial angel investor in medical and biotech companies, and photonics, sensors and diagnostics. He has sat on the Board or acted as an advisor in the early stages of growth.

He was a founder of the British Association for Medical Management and subsequently the Faculty of Medical Management and Leadership. He established a consultancy practice to advise Government, Universities, the NHS and the private sector and has built effective relationships across these sectors. He has chaired or been a member of a number of national committees across patient safety, higher education and digital services and mentored developing executives in the public services.

bottom of page